The Construction Industry Institute reports that rework can swallow up to 20% of construction costs. In pharma, where GMP ...
Speculation is building that President Donald Trump may delay the introduction of his 100% tariff rate on pharmaceutical ...
The AI Structural Biology (AISB) consortium was set up earlier this year to fine-tune OpenFold3, which is being developed by ...
As academic researchers experience a worsening funding crunch and pharma companies are increasingly hungry for large, ...
Purposeful prescribing is the idea of making thoughtful, patient-centred decisions about medication – choices that reflect not only the diagnosis, but also what the patient is going through, what ...
“About a third of women affected by a UTI will go on to have recurrent UTIs. This can happen for several reasons, for ...
Crystalys Therapeutics has emerged from its cocoon with $205 million first-round financing and a potential treatment for gout ...
Post-trial access (PTA) is a mechanism that provides continued access to an investigational medicine to those who benefitted ...
In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with commercial strategy ...
The settlement with New York includes a commitment to repay any taxpayer dollars Indivior received for Opvee, recall all the ...
Sanofi has confirmed it is being investigated by the European Commission for potentially anticompetitive activity in its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback